Skip to main content
Fisher & Paykel Healthcare Corporation Limited (ASX: FPH)
Australia flag Australia · Delayed Price · Currency is AUD
34.18
+0.30 (0.89%)
Dec 20, 2024, 4:10 PM AEST

ASX: FPH Revenue

Fisher & Paykel Healthcare Corporation had revenue of 951.20M NZD in the half year ending September 30, 2024, with 37.74% growth. This brings the company's revenue in the last twelve months to 1.89B, up 11.57% year-over-year. In the fiscal year ending March 31, 2024, Fisher & Paykel Healthcare Corporation had annual revenue of 1.74B with 10.23% growth.

Revenue (ttm)
1.89B NZD
Revenue Growth
+11.57%
P/S Ratio
n/a
Revenue / Employee
268.85K NZD
Employees
7,031
Market Cap
20.11B AUD

Revenue Chart

* This company reports financials in NZD.

History

Fiscal Year End Revenue Change Growth
Mar 31, 20241.74B161.70M10.23%
Mar 31, 20231.58B-100.60M-5.98%
Mar 31, 20221.68B-289.50M-14.69%
Mar 31, 20211.97B707.50M55.99%
Mar 31, 20201.26B193.30M18.06%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CSL Limited 22.18B
ResMed Inc. 6.93B
Pro Medicus Limited 161.50M
Cochlear Limited 2.24B
Sonic Healthcare Limited 8.97B
Telix Pharmaceuticals Limited 645.68M
Ramsay Health Care Limited 16.66B
Neuren Pharmaceuticals Limited 193.34M
Revenue Rankings

Fisher & Paykel Healthcare Corporation News

More News